Search

Author/Creator Williamson, Stephen K.

1. Brief Reports - SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. Issue 3 (March 2016)

Authors:
Lara, Primo N.; Moon, James; Hesketh, Paul J.; Redman, Mary W.; Williamson, Stephen K.; Akerley, Wallace L.; Hirsch, Fred R.; Mack, Philip C.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. Issue 3 (March 2016)

Authors:
Lara, Primo N.; Moon, James; Hesketh, Paul J.; Redman, Mary W.; Williamson, Stephen K.; Akerley, Wallace L.; Hirsch, Fred R.; Mack, Philip C.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search